Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health Corporation, with its nearly 9,900 retail locations and 1,100 MinuteClinic locations, could be the ideal venue to vaccinate America.

CVS Expands Vaccination To These 29 States

CVS has added 12 new states to its Covid-19 vaccine rollout as more supply becomes available.

CVS expands Covid-19 vaccine to 12 more states

CVS Health Corp. said Thursday that it will begin administering COVID-19 vaccines at additional sites nationwide, including seven locations in Illinois and Hawaii, 37 additional locations in New York, 119 locations in California, and 34 locations in Massachusetts. Vaccinations for eligible populations at some of these new locations could begin as soon as March 14.

CVS adds locations where it's administering COVID-19 vaccines nationwide

WOONSOCKET, R.I., March 11, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) has nearly doubled the number of states where select CVS Pharmacy locations are offering COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program (FRPP).

CVS Health Now Offering COVID-19 Vaccines in 29 States

The FY 2021 outlook for CVS Health is mixed, with strength in the retail/LTC and pharmacy services businesses expected to be offset by weakness in the health care benefits segment. My target price of $97.20 for CVS Health is based on a 12 times forward P/E multiple applied to FY 2022 consensus earnings, which implies a 35% upside.

CVS Stock: Buy, Sell, Or Hold In 2021

Target Corp. announced Wednesday that more than 600 stores with CVS Health Corp. locations will administer COVID-19 vaccinations. Target and CVS have already partnered for flu, shingles and pneumonia vaccinations.

CVS locations in Target stores will begin administering COVID019 vaccinations

Bank of New York Mellon

Amdocs

MetLife

Rio Tinto plc Sponsored

Valvoline

Verizon

It's been a shark sell-off lately, especially with tech companies. The time might be right to look at value stocks.

7 Value Stocks To Buy if the Market Falters

Arcos Dorados Hlds

Alibaba

Bristol-Myers

Auxier Asset Management leader Jeff Auxier (Trades, Portfolio) released his fourth-quarter portfolio last week.

Jeff Auxier's Top 5 Buys of the 4th Quarter

With the world focused on the NASDAQ, CVS flies under the radar. I believe CVS stock is one of the most compelling opportunities in the market today.

Why CVS Is My Top Stock Pick For 2021

UnitedHealth Group

We think that CVS Health currently is a better pick compared to UnitedHealth Group. CVS stock trades at about 0.3x trailing revenues, compared to around 1.2x for UNH.

Is CVS Health A Better Pick Over UnitedHealth Stock?

Invesco Dow Jones Industrial Average Dividend ETF

International Paper

iShares U.S. Consumer Goods ETF

S&P Global

Health Care Select Sector SPDR Fund

Seasoned investors have historically loaded up on blue-chip stocks, and that's still true in 2021 The post 7 Blue-Chip Stocks That May Be Perfect For Retirement appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn't matter if you have $500 in savings or $5 million.

7 Blue-Chip Stocks That May Be Perfect For Retirement

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #NationsBenefits--NationsHearing®, a provider of comprehensive and cost-effective hearing aid and services solutions, has announced it has contracted with Aetna®, a CVS Health® company (NYSE: CVS) and one of the leading health insurers in the United States. As of January 1, 2021, eligible Aetna Medicare Advantage plan members have access to a comprehensive hearing benefit. The benefit includes a hearing test at no additional cost and a benefit allowance that can be applied

NationsHearing Contracts with Aetna to Provide Eligible Medicare Advantage Plan Members a Comprehensive Hearing Benefit

Herbalife

Walgreens

3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence

Copart

Denny's

Energizer Holdings

Generac Holdings

Home Depot

Smith & Wesson Brands

Worksport Ltd

With all that has transpired with the novel coronavirus pandemic, natural disasters are the last thing we need. Yet they happen irrespective of our accumulated suffering.

9 Stocks That Are Built to Help in a Natural Disaster

CVS Health Corp. said Wednesday that it will be administering the COVID-19 vaccination in select locations in Alabama, Arizona, Florida, Louisiana, Ohio, and Pennsylvania. The pharmacy retailer has already signed on to administer the vaccine in 11 states, including California, Maryland and New York.

CVS to administer COVID vaccinations in 6 additional states

WOONSOCKET, R.I., Feb. 24, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) has added Alabama, Arizona, Florida, Louisiana, Ohio, and Pennsylvania to the list of states where select CVS Pharmacy locations will offer COVID-19 vaccinations to eligible populations through the Federal Retail...

CVS Health Will Administer COVID-19 Vaccines in Six Additional States

CVS Health said it will begin receiving at least 570,000 Covid-19 vaccine doses weekly as part of the broader effort to increase vaccination at U. S. pharmacies in 17 states.

CVS To Expand Covid-19 Vaccinations To Pharmacies In 17 States

PepsiCo

Exxon Mobil

Kraft Heinz

NextEra Energy

Toyota Motor

Investors keep seeking for Alpha, above-average returns, and leaving value stocks on the shelf. But when the market falls, these stocks will save your portfolio The post 7 Bypassed Value Stocks to Buy Before Speculators Catch On appeared first on InvestorPlace.

7 Bypassed Value Stocks to Buy Before Speculators Catch On

CVS Health will increase investments in affordable housing to address social determinants of health as insurers intensify strategies to reduce costs and improve outcomes beyond covering traditional medical treatments.

CVS Housing Investments Reach $114 Million As Insurers Address Social Determinants

Last week, CVS Health  (NYSE: CVS) reported fourth-quarter earnings that beat Wall Street's expectations as prescription volume lifted sales and the drugstore chain attracted new customers with Covid-19 testing and vaccines. CEO Karen Lynch announced that the drug store chain will accelerate investments to go beyond filling prescriptions into health-care services.

CVS Feels Benefits And Drawbacks From The Pandemic

WOONSOCKET, R.I., Feb. 23, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin to administer vaccines to eligible populations at 81 select CVS...

CVS Health to Administer COVID-19 Vaccines at Over 80 Pharmacy Locations in Florida as Part of Multi-State Activation

The pharmacy retailer and health insurer topped Wall Street estimates but could face some challenges in 2021.

Should You Buy CVS Health Stock After Its Q4 Update?

CVS Health Inc. is looking forward to the chance to meet tons of new shoppers in the coming months as it administers the COVID-19 vaccine, offering the pharmacy retailer a unique business opportunity.

The Ratings Game: CVS says it will engage with millions of new customers as it administers COVID vaccine

Amgen

Air Products and Chemicals

Blackrock Inc

Cisco Systems

Con Ed

Eastman Chemical

Genuine Parts

International Flavors & Fragrances

Illinois Tool Works

Johnson & Johnson

Leggett & Platt

Main Street Capital

Magellan Midstream Partners

Realty Income Corp

Walmart

Equity markets were generally down for the month of January with the S&P 500 finishing down 1%. The Sand In Shoes portfolio finished slightly better, up 0.15% for the month.

News for CVS Health Stock (CVS)